For individuals with cardiovascular disease or stroke, factors such as impaired autonomic regulation, cerebrovascular function, and potential motor or balance deficits need to be considered and monitored during exercise sessions (Billinger et al., 2014)
Weight loss from GLP-1 medications can be rapid (typically 5-15% of body weight over several months), and MS patients must ensure adequate protein and micronutrient intake to support neurological function, immune regulation, and muscle preservation
November 17, 2025
While exenatide provides clinically meaningful glycemic control, its impact on weight loss is relatively modest compared to more recent GLP-1R agents, resulting in less than 3 kg of weight reduction over a 30-week period (DeFronzo et al., 2005
Semaglutide, a medication often prescribed for managing type 2 diabetes, can cause dizziness as a result of gastrointestinal side effects
This episode provides a modifiable foundational template that can be adjusted based on your current fitness level, goals, time constraints, and access to different types of equipment